The National Osteoporosis Foundation (NOF) announced today that Felicia Cosman, M.D., Medical Director of the Clinical Research Center at Helen Hayes Hospital and Professor of Medicine at Columbia University College of Physician and Surgeons in New York, has been selected as its new Editor-in-Chief of Osteoporosis International after an extensive search. Dr. Cosman joins Dr. John Kanis, Co-Editor in Chief representing the International Osteoporosis Foundation (IOF). Osteoporosis International (OI) is an international multi-disciplinary journal, a joint initiative of the IOF and NOF. OI provides a forum for the publication, communication and exchange of current research related to the diagnosis, prevention, treatment and management of osteoporosis and other metabolic bone diseases. The Editor-in-Chief also oversees, in collaboration with IOF, the journal Archives in Osteoporosis.
“We are honored and excited to have Dr. Cosman as Editor-in-Chief of this prestigious journal,” said Robert F. Gagel, M.D., president of NOF. “She is a highly distinguished member of the bone research community, is committed to advancing scientific discovery, and brings with her a strategic vision for a vibrant journal that promotes improved clinical practice through the application of knowledge.”
Dr. Cosman joined Helen Hayes Hospital in West Haverstraw, New York in 1988 where she serves as an osteoporosis specialist, clinical scientist and Medical Director of the Clinical Research Center. She is also Professor of Medicine at Columbia University. Her research has included studies on the causes of osteoporosis and how estrogen, SERMS, vitamin D, bisphosphonates, teriparatide and denosumab work as treatments for osteoporosis. She has also studied the causes of stress fractures and factors influencing the acquisition of peak bone mass in young military cadets at the United States Military Academy. Dr. Cosman has been involved in many research studies evaluating the effectiveness and safety of investigational osteoporosis medications. Her major research focus over the last decade is the use of teriparatide, a bone building medication, in combination with antiresorptive agents, and in novel cyclic regimens, in the treatment of severe osteoporosis.
She is the recipient of research grants from the National Institutes of Health, the Department of Defense, the National Multiple Sclerosis Society, and multiple pharmaceutical companies. Dr. Cosman has published over 130 peer-reviewed articles in the osteoporosis field in journals that include the New England Journal of Medicine and the Journal of the American Medical Association. She is the author of “What Your Doctor May Not Tell You about Osteoporosis (Warner Books)” and coeditor of “Osteoporosis: An Evidence Based Approach to the Prevention of Fractures (American College of Physicians)”. She has also contributed countless chapters to textbooks of endocrinology, rheumatology, gynecology and internal medicine and has served on multiple international task forces including the ASBMR task force on atypical femur fractures and the ASBMR/NOF task force on Goal Directed Osteoporosis Therapy.
Dr. Cosman served as the review editor of Osteoporosis International before being named editor-in-chief, was an Associate Editor for Bone, and is a regular reviewer for theJournal of Clinical Endocrinology and Metabolism, Journal of Bone and Mineral Researchand Calcified Tissue International. Dr. Cosman is a graduate of Cornell University and Stony Brook Medical School. She received her internal medicine training and completed her endocrinology fellowship at Columbia Presbyterian Medical Center in New York City.
An independent search committee reviewed applications from leaders in osteoporosis research and clinical practice during the year-long search process. “We are most grateful to the search committee for its thorough and diligent work to seek and secure the best candidate for this unique and important role,” added Gagel. The editor-in-chief position is a five-year appointment.
Osteoporosis International publishes clinically oriented original research papers, reporting investigational findings in all areas of osteoporosis and its related fields; review articles, reflecting the present state of knowledge in specific areas each month; perspectives and editorials in selected areas, and position statements from both NOF and IOF. OI also publishes; case reports, of uncommon or interesting presentations of the condition. It is the most impactful clinical osteoporosis journal in the world.
About the National Osteoporosis Foundation
Established in 1984, the National Osteoporosis Foundation is the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.